Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationNeuroblastomaPeripheral Blood Stem Cell TransplantationMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyTreatment OutcomeRemission InductionStem CellsSalvage TherapyDisease-Free SurvivalEtoposideCyclophosphamideHodgkin DiseaseMyeloablative AgonistsLymphoma, Non-HodgkinCytarabineRecurrenceCarmustineSurvival RateHematopoietic Stem Cell MobilizationBone Marrow TransplantationGraft vs Host DiseaseThiotepaBone Marrow PurgingVincristineSurvival AnalysisHematologic NeoplasmsLymphoma, Mantle-CellWhole-Body IrradiationAmyloidosisDoxorubicinRetrospective StudiesHematopoietic Stem CellsPrognosisBusulfanBoronic AcidsDexamethasonePyrazinesGraft SurvivalAntibodies, Monoclonal, Murine-DerivedFollow-Up StudiesAntineoplastic Agents, AlkylatingLymphoma, FollicularAntigens, CD34AutograftsLymphoma, T-Cell, PeripheralAntineoplastic AgentsLiver TransplantationThalidomideIfosfamideInduction ChemotherapyTime FactorsMesenchymal Stem Cell TransplantationGranulocyte Colony-Stimulating FactorLeukapheresisLymphomaPrednisonePodophyllotoxinNeoplasm, ResidualMaintenance ChemotherapyLymphoma, Large B-Cell, DiffuseTransplantation ChimeraTissue DonorsCord Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteCell TransplantationKidney TransplantationEnteropathy-Associated T-Cell LymphomaLymphoma, B-CellEmbryonic Stem CellsMyelodysplastic SyndromesMitoxantroneIdarubicinNeoplasms, Second PrimaryCisplatinLeukemia, Plasma CellInfusions, SpinalCarboplatinProspective StudiesAdult Stem CellsBlood Component RemovalCell DifferentiationChemotherapy, AdjuvantImmunosuppressive AgentsAntibodies, MonoclonalNeoplasm Recurrence, LocalHistocompatibility TestingFeasibility StudiesDrug Administration ScheduleLeukemia, MyeloidFatal OutcomeKeratins, Type IILife TablesNeutropenia